Antimicrobial resistance in ESKAPE pathogens
Antimicrobial-resistant ESKAPE (E nterococcus faecium, S taphylococcus aureus, K
lebsiella pneumoniae, A cinetobacter baumannii, P seudomonas aeruginosa, and E …
lebsiella pneumoniae, A cinetobacter baumannii, P seudomonas aeruginosa, and E …
Epidemiology of β-lactamase-producing pathogens
K Bush, PA Bradford - Clinical microbiology reviews, 2020 - Am Soc Microbiol
SUMMARY β-Lactam antibiotics have been widely used as therapeutic agents for the past
70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases …
70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases …
The urgent need for metallo-β-lactamase inhibitors: an unattended global threat
Due to their superior tolerability and efficacy, β-lactams are the most potent and prescribed
class of antibiotics in the clinic. The emergence of resistance to those antibiotics, mainly due …
class of antibiotics in the clinic. The emergence of resistance to those antibiotics, mainly due …
Metallo-β-lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design
G Bahr, LJ Gonzalez, AJ Vila - Chemical reviews, 2021 - ACS Publications
Antimicrobial resistance is one of the major problems in current practical medicine. The
spread of genes coding for resistance determinants among bacteria challenges the use of …
spread of genes coding for resistance determinants among bacteria challenges the use of …
Past and present perspectives on β-lactamases
K Bush - Antimicrobial agents and chemotherapy, 2018 - Am Soc Microbiol
ABSTRACT β-Lactamases, the major resistance determinant for β-lactam antibiotics in Gram-
negative bacteria, are ancient enzymes whose origins can be traced back millions of years …
negative bacteria, are ancient enzymes whose origins can be traced back millions of years …
Interplay between β-lactamases and new β-lactamase inhibitors
K Bush, PA Bradford - Nature Reviews Microbiology, 2019 - nature.com
Resistance to β-lactam antibiotics in Gram-negative bacteria is commonly associated with
production of β-lactamases, including extended-spectrum β-lactamases (ESBLs) and …
production of β-lactamases, including extended-spectrum β-lactamases (ESBLs) and …
[HTML][HTML] Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae
RM Martin, MA Bachman - Frontiers in cellular and infection …, 2018 - frontiersin.org
Klebsiella pneumoniae is a Gram-negative pathogen that has a large accessory genome of
plasmids and chromosomal gene loci. This accessory genome divides K. pneumoniae …
plasmids and chromosomal gene loci. This accessory genome divides K. pneumoniae …
The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace
LK Logan, RA Weinstein - The Journal of infectious diseases, 2017 - academic.oup.com
Carbapenem-resistant Enterobacteriaceae (CRE) are a serious public health threat.
Infections due to these organisms are associated with significant morbidity and mortality …
Infections due to these organisms are associated with significant morbidity and mortality …
Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline
SE Boyd, DM Livermore, DC Hooper… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Modern medicine is threatened by the global rise of antibiotic resistance, especially among
Gram-negative bacteria. Metallo-β-lactamase (MBL) enzymes are a particular concern and …
Gram-negative bacteria. Metallo-β-lactamase (MBL) enzymes are a particular concern and …
Present and future of carbapenem-resistant Enterobacteriaceae infections
B Suay-García, MT Pérez-Gracia - Advances in clinical …, 2021 - taylorfrancis.com
This chapter analyzes the epidemiology of Carbapenem-Resistant Enterobacteriaceae
(CRE) as well as current and future treatment options against the increasingly resistant …
(CRE) as well as current and future treatment options against the increasingly resistant …